Correction: Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers (BMC Pharmacology and Toxicology (2019) 20 (5) DOI: 10.1186/s40360-018-0280-8)

Nahum Méndez-Sánchez, Miguel Dibildox-Martinez, Jahir Sosa-Noguera, Ramón Sánchez-Medal, Francisco J. Flores-Murrieta

Research output: Contribution to journalComment/debate

Abstract

Following publication of the original article [1], the author reported their given name have been erroneously tagged as their family names. The correct list is: Given name Nahum Family name Mendez-Sanchez, Given name Miguel Family name Dibildox-Martinez, Given name Jahir Family name Sosa-Noguera Jahir, Given name Ramon Family name Sanchez-Medal, Given name Francisco J. Family name Flores-Murrieta. It has been corrected in the original article as well. The publisher apologizes for any inconvenience caused by this error.

Original languageEnglish
Article number14
JournalBMC Pharmacology and Toxicology
Volume20
Issue number1
DOIs
StatePublished - 22 Feb 2019

Fingerprint

Dive into the research topics of 'Correction: Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers (BMC Pharmacology and Toxicology (2019) 20 (5) DOI: 10.1186/s40360-018-0280-8)'. Together they form a unique fingerprint.

Cite this